CN113908076A - Whitening mask liquid and preparation method thereof - Google Patents
Whitening mask liquid and preparation method thereof Download PDFInfo
- Publication number
- CN113908076A CN113908076A CN202111370309.6A CN202111370309A CN113908076A CN 113908076 A CN113908076 A CN 113908076A CN 202111370309 A CN202111370309 A CN 202111370309A CN 113908076 A CN113908076 A CN 113908076A
- Authority
- CN
- China
- Prior art keywords
- parts
- mask liquid
- solution
- whitening mask
- root extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000002087 whitening effect Effects 0.000 title claims abstract description 48
- 239000007788 liquid Substances 0.000 title claims abstract description 39
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- 239000000243 solution Substances 0.000 claims abstract description 57
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 claims abstract description 42
- 239000001243 zingiber officinale rosc. root absolute Substances 0.000 claims abstract description 33
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 26
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 22
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims abstract description 22
- LBQIJVLKGVZRIW-ZDUSSCGKSA-N glabridin Chemical compound C1([C@H]2CC3=CC=C4OC(C=CC4=C3OC2)(C)C)=CC=C(O)C=C1O LBQIJVLKGVZRIW-ZDUSSCGKSA-N 0.000 claims abstract description 22
- 229940093767 glabridin Drugs 0.000 claims abstract description 22
- PMPYOYXFIHXBJI-ZDUSSCGKSA-N glabridin Natural products C1([C@H]2CC=3C=CC4=C(C=3OC2)CCC(O4)(C)C)=CC=C(O)C=C1O PMPYOYXFIHXBJI-ZDUSSCGKSA-N 0.000 claims abstract description 22
- LBQIJVLKGVZRIW-UHFFFAOYSA-N glabridine Natural products C1OC2=C3C=CC(C)(C)OC3=CC=C2CC1C1=CC=C(O)C=C1O LBQIJVLKGVZRIW-UHFFFAOYSA-N 0.000 claims abstract description 22
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims abstract description 22
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 claims abstract description 16
- 229920002884 Laureth 4 Polymers 0.000 claims abstract description 16
- 229910019142 PO4 Inorganic materials 0.000 claims abstract description 16
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims abstract description 16
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 claims abstract description 16
- SFNALCNOMXIBKG-UHFFFAOYSA-N ethylene glycol monododecyl ether Chemical compound CCCCCCCCCCCCOCCO SFNALCNOMXIBKG-UHFFFAOYSA-N 0.000 claims abstract description 16
- 229940061515 laureth-4 Drugs 0.000 claims abstract description 16
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims abstract description 16
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims abstract description 16
- 239000010452 phosphate Substances 0.000 claims abstract description 16
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 claims abstract description 16
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 claims abstract description 12
- ZGSCRDSBTNQPMS-UJURSFKZSA-N 3-O-Ethylascorbic acid Chemical compound CCOC1=C(O)C(=O)O[C@@H]1[C@@H](O)CO ZGSCRDSBTNQPMS-UJURSFKZSA-N 0.000 claims abstract description 12
- 229940120145 3-o-ethylascorbic acid Drugs 0.000 claims abstract description 12
- BJRNKVDFDLYUGJ-ZIQFBCGOSA-N alpha-Arbutin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-ZIQFBCGOSA-N 0.000 claims abstract description 12
- 229940033280 alpha-arbutin Drugs 0.000 claims abstract description 12
- 229940089468 hydroxyethylpiperazine ethane sulfonic acid Drugs 0.000 claims abstract description 12
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims abstract description 11
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 claims abstract description 11
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 claims abstract description 11
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 claims abstract description 11
- 229940015975 1,2-hexanediol Drugs 0.000 claims abstract description 11
- LXAHHHIGZXPRKQ-UHFFFAOYSA-N 5-fluoro-2-methylpyridine Chemical compound CC1=CC=C(F)C=N1 LXAHHHIGZXPRKQ-UHFFFAOYSA-N 0.000 claims abstract description 11
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims abstract description 11
- 229920002498 Beta-glucan Polymers 0.000 claims abstract description 11
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 claims abstract description 11
- 241000221095 Simmondsia Species 0.000 claims abstract description 11
- 235000004433 Simmondsia californica Nutrition 0.000 claims abstract description 11
- 229920002385 Sodium hyaluronate Polymers 0.000 claims abstract description 11
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims abstract description 11
- 229960000458 allantoin Drugs 0.000 claims abstract description 11
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims abstract description 11
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 claims abstract description 11
- 229960005070 ascorbic acid Drugs 0.000 claims abstract description 11
- 235000010323 ascorbic acid Nutrition 0.000 claims abstract description 11
- 239000011668 ascorbic acid Substances 0.000 claims abstract description 11
- 229940036350 bisabolol Drugs 0.000 claims abstract description 11
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 claims abstract description 11
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims abstract description 11
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 claims abstract description 11
- 229940101267 panthenol Drugs 0.000 claims abstract description 11
- 235000020957 pantothenol Nutrition 0.000 claims abstract description 11
- 239000011619 pantothenol Substances 0.000 claims abstract description 11
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 claims abstract description 11
- 229940010747 sodium hyaluronate Drugs 0.000 claims abstract description 11
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims abstract description 11
- 229940032094 squalane Drugs 0.000 claims abstract description 11
- 235000015112 vegetable and seed oil Nutrition 0.000 claims abstract description 11
- 229920001285 xanthan gum Polymers 0.000 claims abstract description 11
- 239000000230 xanthan gum Substances 0.000 claims abstract description 11
- 229940082509 xanthan gum Drugs 0.000 claims abstract description 11
- 235000010493 xanthan gum Nutrition 0.000 claims abstract description 11
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 claims abstract description 9
- 239000002994 raw material Substances 0.000 claims abstract description 8
- 239000007983 Tris buffer Substances 0.000 claims abstract description 7
- 238000003756 stirring Methods 0.000 claims description 46
- 238000010438 heat treatment Methods 0.000 claims description 30
- 239000000203 mixture Substances 0.000 claims description 20
- 238000001816 cooling Methods 0.000 claims description 18
- OEWBEINAQKIQLZ-CMRBMDBWSA-N [(2s)-2-[(2r)-3,4-bis(2-hexyldecanoyloxy)-5-oxo-2h-furan-2-yl]-2-(2-hexyldecanoyloxy)ethyl] 2-hexyldecanoate Chemical compound CCCCCCCCC(CCCCCC)C(=O)OC[C@H](OC(=O)C(CCCCCC)CCCCCCCC)[C@H]1OC(=O)C(OC(=O)C(CCCCCC)CCCCCCCC)=C1OC(=O)C(CCCCCC)CCCCCCCC OEWBEINAQKIQLZ-CMRBMDBWSA-N 0.000 claims description 11
- 239000011259 mixed solution Substances 0.000 claims description 10
- 238000004140 cleaning Methods 0.000 claims description 5
- 230000000249 desinfective effect Effects 0.000 claims description 5
- 238000011049 filling Methods 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- 238000004806 packaging method and process Methods 0.000 claims description 5
- 239000002245 particle Substances 0.000 claims description 5
- 238000004321 preservation Methods 0.000 claims description 5
- 229940074410 trehalose Drugs 0.000 claims description 5
- 239000002537 cosmetic Substances 0.000 abstract description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 210000003491 skin Anatomy 0.000 description 4
- 239000004721 Polyphenylene oxide Substances 0.000 description 3
- 238000005282 brightening Methods 0.000 description 3
- 238000000265 homogenisation Methods 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 229920000570 polyether Polymers 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 229920000832 Cutin Polymers 0.000 description 2
- 102000003425 Tyrosinase Human genes 0.000 description 2
- 108060008724 Tyrosinase Proteins 0.000 description 2
- 239000002085 irritant Substances 0.000 description 2
- 231100000021 irritant Toxicity 0.000 description 2
- 230000037307 sensitive skin Effects 0.000 description 2
- 102100030310 5,6-dihydroxyindole-2-carboxylic acid oxidase Human genes 0.000 description 1
- 101710163881 5,6-dihydroxyindole-2-carboxylic acid oxidase Proteins 0.000 description 1
- 102100031413 L-dopachrome tautomerase Human genes 0.000 description 1
- 108010007013 Melanocyte-Stimulating Hormones Proteins 0.000 description 1
- 102400000740 Melanocyte-stimulating hormone alpha Human genes 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 101710200814 Melanotropin alpha Proteins 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 108010051081 dopachrome isomerase Proteins 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 230000008099 melanin synthesis Effects 0.000 description 1
- 210000002752 melanocyte Anatomy 0.000 description 1
- 210000002780 melanosome Anatomy 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- WHNFPRLDDSXQCL-UAZQEYIDSA-N α-msh Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(N)=O)NC(=O)[C@H](CO)NC(C)=O)C1=CC=C(O)C=C1 WHNFPRLDDSXQCL-UAZQEYIDSA-N 0.000 description 1
- SFVVQRJOGUKCEG-OPQSFPLASA-N β-MSH Chemical compound C1C[C@@H](O)[C@H]2C(COC(=O)[C@@](O)([C@@H](C)O)C(C)C)=CCN21 SFVVQRJOGUKCEG-OPQSFPLASA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
The invention discloses a whitening mask liquid and a preparation method thereof, and relates to the technical field of whitening cosmetics, wherein the whitening mask liquid comprises the following raw material components in parts by weight: 66.45-93.669 parts of water, 1-5 parts of butanediol, 0.1-1 part of 1, 2-pentanediol, 261-3 parts of glyceryl polyether-261-3 parts of squalane, 0.5-3 parts of jojoba seed oil, 0.5-3 parts of caprylic/capric triglyceride, 0.1-1 part of hydroxyethyl piperazine ethane sulfonic acid, 0.01-1 part of ascorbic acid tetraisopalmitate, 0.1-2 parts of 3-o-ethyl ascorbic acid, 0.1-1 part of alpha-arbutin, 0.001-0.1 part of glabridin, 0.5-2 parts of trehalose, 0.5-2 parts of ginger root extract solution, 0.3-1 part of p-hydroxyacetophenone, 0.5-1 part of 1, 2-hexanediol, 0.1-1 part of beta-glucan, 0.1-1 part of tris (laureth-4) phosphate, 0.1-1 part of panthenol, 0.1-0.5 part of xanthan gum, 0.1-0.5 part of dipotassium glycyrrhizinate, 0.1-0.3 part of allantoin, 0.01-0.1 part of sodium hyaluronate and 0.01-0.05 part of EDTA disodium; the ginger root extract solution consists of bisabolol and a ginger root extract.
Description
Technical Field
The invention relates to the technical field of whitening cosmetics, and particularly relates to a whitening mask liquid and a preparation method thereof.
Background
Many different types of whitening mask products are available on the market, and some mask liquids of the whitening masks contain acid components, have the effect of forcibly peeling off cutin, and are irritant to skin and incapable of being used by sensitive skin. Or the facial mask liquid contains some components for instantly moisturizing and brightening, and has no actual whitening effect and no idle work after being used.
Disclosure of Invention
Aiming at the defects in the prior art, the invention provides the whitening mask liquid and the preparation method thereof.
The whitening mask liquid comprises the following raw material components in parts by weight:
66.45-93.669 parts of water, 1-5 parts of butanediol, 0.1-1 part of 1, 2-pentanediol, 261-3 parts of glyceryl polyether-261-3 parts of squalane, 0.5-3 parts of jojoba seed oil, 0.5-3 parts of caprylic/capric triglyceride, 0.1-1 part of hydroxyethyl piperazine ethane sulfonic acid, 0.01-1 part of ascorbic acid tetraisopalmitate, 0.1-2 parts of 3-o-ethyl ascorbic acid, 0.1-1 part of alpha-arbutin, 0.001-0.1 part of glabridin, 0.5-2 parts of trehalose, 0.5-2 parts of ginger root extract solution, 0.3-1 part of p-hydroxyacetophenone, 0.5-1 part of 1, 2-hexanediol, 0.1-1 part of beta-glucan, 0.1-1 part of tris (laureth-4) phosphate, 0.1-1 part of panthenol, 0.1-0.5 part of xanthan gum, 0.1-0.5 part of dipotassium glycyrrhizinate, 0.1-0.3 part of allantoin, 0.01-0.1 part of sodium hyaluronate and 0.01-0.05 part of EDTA disodium.
The ginger root extract solution consists of bisabolol and a ginger root extract.
Preferably, the ratio of the weight parts of the bisabolol to the weight parts of the ginger root extract in the ginger root extract solution is 99: 1.
Preferably, the water content of the tris (laureth-4) phosphate is 9% and the water content of the dipotassium glycyrrhizinate is 8%.
The preparation method of the whitening mask liquid comprises the following steps:
s1, adding a ginger root extract solution into ascorbyl tetraisopalmitate, and stirring until the mixture is completely clear and transparent to prepare an ascorbyl tetraisopalmitate solution for later use;
s2, adding p-hydroxyacetophenone into one fourth of butanediol, heating while stirring until the mixture is completely clear and transparent, and preparing a p-hydroxyacetophenone solution for later use;
s3, adding glabridin into one fourth of caprylic/capric triglyceride, heating while stirring until the mixture is completely clear and transparent, and preparing glabridin solution for later use;
s4, cleaning and disinfecting the equipment for later use;
s5, sequentially adding water, the remaining three-quarter of butanediol, 1, 2-pentanediol, glyceryl polyether-26, trehalose, panthenol, xanthan gum, dipotassium glycyrrhizinate, allantoin, sodium hyaluronate and EDTA disodium into a water phase pot, heating and stirring until no particles exist, and preserving heat for later use to prepare a mixed solution A;
s6, adding squalane, jojoba seed oil, the remaining three quarters of caprylic/capric triglyceride and tri (laureth-4) phosphate into the mixed solution A, homogenizing until the mixture is completely uniform, keeping the temperature, cooling for the first time, adding an ascorbic acid tetraisopalmitate solution, a p-hydroxyacetophenone solution and a glabridin solution, stirring for the first time, cooling for the second time, adding hydroxyethyl piperazine ethanesulfonic acid, 3-o-ethyl ascorbic acid, alpha-arbutin, 1, 2-hexanediol and beta-glucan, stirring for the second time, filtering, filling and packaging to obtain the whitening mask liquid.
Preferably, in step S2, the heating is performed to 55-65 ℃.
Preferably, in step S3, the heating is performed to 65-75 ℃.
Preferably, in step S5, the heating is performed to 85-90 deg.C, and the stirring is performed at 30-50rpm for 10-15 min.
Preferably, in step S6, the homogenizing is performed for 10-15 minutes, and the heat preservation is performed for 5-10 minutes.
Preferably, in step S6, the first cooling is performed to 55 to 60 ℃, and the first stirring is performed at a rotation speed of 40 to 60rpm for 5 to 10 minutes.
Preferably, in step S6, the temperature is decreased to 40-45 ℃ for the second time, and the second stirring is performed at a rotation speed of 40-60rpm for 5-10 minutes.
The application of the whitening mask liquid provided by the invention is as follows: can be applied to various parts of body.
The invention has the beneficial effects that:
(1) the whitening mask liquid provided by the invention is non-irritant, can be used for sensitive skin, and has the effects of instant brightening, long-acting whitening and freckle removing.
(2) The glabridin in the raw material components of the whitening mask liquid provided by the invention can simultaneously act on tyrosinase, DHICA oxidase, dopachrome tautomerase and alpha-MSH melanotropin, and inhibit the proliferation of melanocytes and B16 cells, thereby achieving the effects of inhibiting melanin production, inhibiting melanosome transfer and reducing the total melanin. In addition, the matching of the water-soluble 3-o-ethyl ascorbic acid and the oil-soluble ascorbic acid tetraisopalmitate can play a role in inhibiting tyrosinase and reducing melanin. And the generation of melanin is synergistically inhibited by adopting alpha-arbutin, so that multi-channel whitening is realized. In addition, the hydroxyethyl piperazine ethane sulfonic acid can soften cutin, and has the effects of smoothing and softening skin, brightening skin color and assisting in whitening.
(3) The preparation method of the whitening mask liquid provided by the invention is simple to operate, stable in technology, easy in obtaining of raw materials, excellent in effect of the prepared whitening mask liquid and high in commercial value.
Detailed Description
Hereinafter, embodiments of the present invention will be described in detail. The following examples are only for illustrating the technical solutions of the present invention more clearly, and therefore are only examples, and the protection scope of the present invention is not limited thereby.
It is to be noted that, unless otherwise specified, technical or scientific terms used herein shall have the ordinary meaning as understood by those skilled in the art to which the invention pertains.
Example 1
The embodiment provides a whitening mask liquid which comprises the following raw material components in parts by weight: 80.115 parts of water, 3 parts of butanediol, 0.55 part of 1, 2-pentanediol, 262 parts of glycerol polyether, 1.75 parts of squalane, 1.75 parts of jojoba seed oil, 1.75 parts of caprylic/capric triglyceride, 0.55 part of hydroxyethyl piperazine ethane sulfonic acid, 0.5 part of ascorbic acid tetraisopalmitate, 1 part of 3-o-ethyl ascorbic acid, 0.55 part of alpha-arbutin, 0.05 part of glabridin, 1.25 parts of trehalose, 1.25 parts of ginger root extract solution, 0.65 part of p-hydroxyacetophenone, 0.75 part of 1, 2-hexanediol, 0.55 part of beta-glucan, 0.55 part of tris (laureth-4) phosphate, 0.55 part of panthenol, 0.3 part of xanthan gum, 0.3 part of dipotassium glycyrrhizinate, 0.2 part of allantoin, 0.055 part of sodium hyaluronate and 0.03 part of EDTA disodium.
The ginger root extract solution consists of bisabolol and a ginger root extract, and the weight part ratio of the bisabolol to the ginger root extract in the ginger root extract solution is 99: 1.
The water content of the tri (laureth-4) phosphate is 9 percent, and the water content of the dipotassium glycyrrhizinate is 8 percent.
The preparation method of the whitening mask liquid comprises the following steps:
s1, adding a ginger root extract solution into ascorbyl tetraisopalmitate, and stirring until the mixture is completely clear and transparent to prepare an ascorbyl tetraisopalmitate solution for later use;
s2, adding p-hydroxyacetophenone into one fourth of butanediol, heating while stirring until the mixture is completely clear and transparent, and preparing a p-hydroxyacetophenone solution for later use;
s3, adding glabridin into one fourth of caprylic/capric triglyceride, heating while stirring until the mixture is completely clear and transparent, and preparing glabridin solution for later use;
s4, cleaning and disinfecting the equipment for later use;
s5, sequentially adding water, the remaining three-quarter of butanediol, 1, 2-pentanediol, glyceryl polyether-26, trehalose, panthenol, xanthan gum, dipotassium glycyrrhizinate, allantoin, sodium hyaluronate and EDTA disodium into a water phase pot, heating and stirring until no particles exist, and preserving heat for later use to prepare a mixed solution A;
s6, adding squalane, jojoba seed oil, the remaining three quarters of caprylic/capric triglyceride and tri (laureth-4) phosphate into the mixed solution A, homogenizing until the mixture is completely uniform, keeping the temperature, cooling for the first time, adding an ascorbic acid tetraisopalmitate solution, a p-hydroxyacetophenone solution and a glabridin solution, stirring for the first time, cooling for the second time, adding hydroxyethyl piperazine ethanesulfonic acid, 3-o-ethyl ascorbic acid, alpha-arbutin, 1, 2-hexanediol and beta-glucan, stirring for the second time, filtering, filling and packaging to obtain the whitening mask liquid.
In step S2, the heating is performed to 60 ℃.
In step S3, the heating is performed to 70 ℃.
In step S5, the heating is performed to 90 ℃, and the stirring is performed at 50rpm for 15 minutes.
In step S6, the homogenization is carried out for 15 minutes, and the heat preservation is carried out for 10 minutes.
In step S6, the first cooling is performed to 60 ℃, and the first stirring is performed at a rotation speed of 50rpm for 10 minutes.
In step S6, the second cooling is performed to 45 ℃, and the second stirring is performed at 50rpm for 10 minutes.
Example 2
The embodiment provides a whitening mask liquid which comprises the following raw material components in parts by weight: 93.669 parts of water, 1 part of butanediol, 0.1 part of 1, 2-pentanediol, 261 parts of glycerol polyether, 0.5 part of squalane, 0.5 part of jojoba seed oil, 0.5 part of caprylic/capric triglyceride, 0.1 part of hydroxyethyl piperazine ethane sulfonic acid, 0.01 part of ascorbic acid tetraisopalmitate, 0.1 part of 3-o-ethyl ascorbic acid, 0.1 part of alpha-arbutin, 0.001 part of glabridin, 0.5 part of trehalose, 0.5 part of ginger root extract solution, 0.3 part of p-hydroxyacetophenone, 0.5 part of 1, 2-hexanediol, 0.1 part of beta-glucan, 0.1 part of tris (laureth-4) phosphate, 0.1 part of panthenol, 0.1 part of xanthan gum, 0.1 part of dipotassium glycyrrhizinate, 0.1 part of allantoin, 0.01 part of sodium hyaluronate and 0.01 part of EDTA disodium.
The ginger root extract solution consists of bisabolol and a ginger root extract, and the weight part ratio of the bisabolol to the ginger root extract in the ginger root extract solution is 99: 1.
The water content of the tri (laureth-4) phosphate is 9 percent, and the water content of the dipotassium glycyrrhizinate is 8 percent.
The preparation method of the whitening mask liquid comprises the following steps:
s1, adding a ginger root extract solution into ascorbyl tetraisopalmitate, and stirring until the mixture is completely clear and transparent to prepare an ascorbyl tetraisopalmitate solution for later use;
s2, adding p-hydroxyacetophenone into one fourth of butanediol, heating while stirring until the mixture is completely clear and transparent, and preparing a p-hydroxyacetophenone solution for later use;
s3, adding glabridin into one fourth of caprylic/capric triglyceride, heating while stirring until the mixture is completely clear and transparent, and preparing glabridin solution for later use;
s4, cleaning and disinfecting the equipment for later use;
s5, sequentially adding water, the remaining three-quarter of butanediol, 1, 2-pentanediol, glyceryl polyether-26, trehalose, panthenol, xanthan gum, dipotassium glycyrrhizinate, allantoin, sodium hyaluronate and EDTA disodium into a water phase pot, heating and stirring until no particles exist, and preserving heat for later use to prepare a mixed solution A;
s6, adding squalane, jojoba seed oil, the remaining three quarters of caprylic/capric triglyceride and tri (laureth-4) phosphate into the mixed solution A, homogenizing until the mixture is completely uniform, keeping the temperature, cooling for the first time, adding an ascorbic acid tetraisopalmitate solution, a p-hydroxyacetophenone solution and a glabridin solution, stirring for the first time, cooling for the second time, adding hydroxyethyl piperazine ethanesulfonic acid, 3-o-ethyl ascorbic acid, alpha-arbutin, 1, 2-hexanediol and beta-glucan, stirring for the second time, filtering, filling and packaging to obtain the whitening mask liquid.
In step S2, the heating is performed to 60 ℃.
In step S3, the heating is performed to 70 ℃.
In step S5, the heating is performed to 90 ℃, and the stirring is performed at 50rpm for 15 minutes.
In step S6, the homogenization is carried out for 15 minutes, and the heat preservation is carried out for 10 minutes.
In step S6, the first cooling is performed to 60 ℃, and the first stirring is performed at a rotation speed of 50rpm for 10 minutes.
In step S6, the second cooling is performed to 45 ℃, and the second stirring is performed at 50rpm for 10 minutes.
Example 3
The embodiment provides a whitening mask liquid which comprises the following raw material components in parts by weight: 66.45 parts of water, 5 parts of butanediol, 1 part of 1, 2-pentanediol, 263 parts of glyceryl polyether, 3 parts of squalane, 3 parts of jojoba seed oil, 3 parts of caprylic/capric triglyceride, 1 part of hydroxyethyl piperazine ethane sulfonic acid, 1 part of ascorbyl tetraisopalmitate, 2 parts of 3-o-ethyl ascorbic acid, 1 part of alpha-arbutin, 0.1 part of glabridin, 2 parts of trehalose, 2 parts of ginger root extract solution, 1 part of p-hydroxyacetophenone, 1 part of 1, 2-hexanediol, 1 part of beta-glucan, 1 part of tris (laureth-4) phosphate, 1 part of panthenol, 0.5 part of xanthan gum, 0.5 part of dipotassium glycyrrhizinate, 0.3 part of allantoin, 0.1 part of sodium hyaluronate and 0.05 part of EDTA disodium.
The ginger root extract solution consists of bisabolol and a ginger root extract, and the weight part ratio of the bisabolol to the ginger root extract in the ginger root extract solution is 99: 1.
The water content of the tri (laureth-4) phosphate is 9 percent, and the water content of the dipotassium glycyrrhizinate is 8 percent.
The preparation method of the whitening mask liquid comprises the following steps:
s1, adding a ginger root extract solution into ascorbyl tetraisopalmitate, and stirring until the mixture is completely clear and transparent to prepare an ascorbyl tetraisopalmitate solution for later use;
s2, adding p-hydroxyacetophenone into one fourth of butanediol, heating while stirring until the mixture is completely clear and transparent, and preparing a p-hydroxyacetophenone solution for later use;
s3, adding glabridin into one fourth of caprylic/capric triglyceride, heating while stirring until the mixture is completely clear and transparent, and preparing glabridin solution for later use;
s4, cleaning and disinfecting the equipment for later use;
s5, sequentially adding water, the remaining three-quarter of butanediol, 1, 2-pentanediol, glyceryl polyether-26, trehalose, panthenol, xanthan gum, dipotassium glycyrrhizinate, allantoin, sodium hyaluronate and EDTA disodium into a water phase pot, heating and stirring until no particles exist, and preserving heat for later use to prepare a mixed solution A;
s6, adding squalane, jojoba seed oil, the remaining three quarters of caprylic/capric triglyceride and tri (laureth-4) phosphate into the mixed solution A, homogenizing until the mixture is completely uniform, keeping the temperature, cooling for the first time, adding an ascorbic acid tetraisopalmitate solution, a p-hydroxyacetophenone solution and a glabridin solution, stirring for the first time, cooling for the second time, adding hydroxyethyl piperazine ethanesulfonic acid, 3-o-ethyl ascorbic acid, alpha-arbutin, 1, 2-hexanediol and beta-glucan, stirring for the second time, filtering, filling and packaging to obtain the whitening mask liquid.
In step S2, the heating is performed to 60 ℃.
In step S3, the heating is performed to 70 ℃.
In step S5, the heating is performed to 90 ℃, and the stirring is performed at 50rpm for 15 minutes.
In step S6, the homogenization is carried out for 15 minutes, and the heat preservation is carried out for 10 minutes.
In step S6, the first cooling is performed to 60 ℃, and the first stirring is performed at a rotation speed of 50rpm for 10 minutes.
In step S6, the second cooling is performed to 45 ℃, and the second stirring is performed at 50rpm for 10 minutes.
Test examples
Example 1
Testing the effect of the whitening mask solution prepared in example 1
The test method comprises the following steps: randomly selecting local 22-58 year-old testers, carrying out no limitation on the nature, continuously using the whitening mask liquid provided in the example 1 once a day and 5g once, uniformly coating the whitening mask liquid on the face, and testing the melanin value of the skin of the testers, wherein the results are shown in the table 1.
TABLE 1
As can be seen from table 1, the whitening mask solution provided in example 1 of the present invention can achieve a significant whitening effect after being continuously used for 28 days.
Finally, it should be noted that: the above embodiments are only used to illustrate the technical solution of the present invention, and not to limit the same; while the invention has been described in detail and with reference to the foregoing embodiments, it will be understood by those skilled in the art that: the technical solutions described in the foregoing embodiments may still be modified, or some or all of the technical features may be equivalently replaced; such modifications and substitutions do not depart from the spirit and scope of the present invention, and they should be construed as being included in the following claims and description.
Claims (10)
1. The whitening mask liquid is characterized in that: the whitening mask liquid comprises the following raw material components in parts by weight: 66.45-93.669 parts of water, 1-5 parts of butanediol, 0.1-1 part of 1, 2-pentanediol, 261-3 parts of glyceryl polyether-261-3 parts of squalane, 0.5-3 parts of jojoba seed oil, 0.5-3 parts of caprylic/capric triglyceride, 0.1-1 part of hydroxyethyl piperazine ethane sulfonic acid, 0.01-1 part of ascorbic acid tetraisopalmitate, 0.1-2 parts of 3-o-ethyl ascorbic acid, 0.1-1 part of alpha-arbutin, 0.001-0.1 part of glabridin, 0.5-2 parts of trehalose, 0.5-2 parts of ginger root extract solution, 0.3-1 part of p-hydroxyacetophenone, 0.5-1 part of 1, 2-hexanediol, 0.1-1 part of beta-glucan, 0.1-1 part of tris (laureth-4) phosphate, 0.1-1 part of panthenol, 0.1-0.5 part of xanthan gum, 0.1-0.5 part of dipotassium glycyrrhizinate, 0.1-0.3 part of allantoin, 0.01-0.1 part of sodium hyaluronate and 0.01-0.05 part of EDTA disodium; the ginger root extract solution consists of bisabolol and a ginger root extract.
2. The whitening mask liquid according to claim 1, characterized in that: the weight part ratio of the bisabolol to the ginger root extract in the ginger root extract solution is 99: 1.
3. The whitening mask liquid according to claim 1, characterized in that: the water content of the tri (laureth-4) phosphate is 9 percent, and the water content of the dipotassium glycyrrhizinate is 8 percent.
4. The preparation method of the whitening mask liquid according to any one of claims 1 to 3, which is characterized by comprising the following steps: the preparation method comprises the following steps:
s1, adding a ginger root extract solution into ascorbyl tetraisopalmitate, and stirring until the mixture is completely clear and transparent to prepare an ascorbyl tetraisopalmitate solution for later use;
s2, adding p-hydroxyacetophenone into one fourth of butanediol, heating while stirring until the mixture is completely clear and transparent, and preparing a p-hydroxyacetophenone solution for later use;
s3, adding glabridin into one fourth of caprylic/capric triglyceride, heating while stirring until the mixture is completely clear and transparent, and preparing glabridin solution for later use;
s4, cleaning and disinfecting the equipment for later use;
s5, sequentially adding water, the remaining three-quarter of butanediol, 1, 2-pentanediol, glyceryl polyether-26, trehalose, panthenol, xanthan gum, dipotassium glycyrrhizinate, allantoin, sodium hyaluronate and EDTA disodium into a water phase pot, heating and stirring until no particles exist, and preserving heat for later use to prepare a mixed solution A;
s6, adding squalane, jojoba seed oil, the remaining three quarters of caprylic/capric triglyceride and tri (laureth-4) phosphate into the mixed solution A, homogenizing until the mixture is completely uniform, keeping the temperature, cooling for the first time, adding an ascorbic acid tetraisopalmitate solution, a p-hydroxyacetophenone solution and a glabridin solution, stirring for the first time, cooling for the second time, adding hydroxyethyl piperazine ethanesulfonic acid, 3-o-ethyl ascorbic acid, alpha-arbutin, 1, 2-hexanediol and beta-glucan, stirring for the second time, filtering, filling and packaging to obtain the whitening mask liquid.
5. The preparation method of the whitening mask liquid according to claim 4, characterized by comprising the following steps: in step S2, the heating is carried out to 55-65 ℃.
6. The preparation method of the whitening mask liquid according to claim 4, characterized by comprising the following steps: in step S3, the heating is carried out to 65-75 ℃.
7. The preparation method of the whitening mask liquid according to claim 4, characterized by comprising the following steps: in step S5, the heating is to 85-90 deg.C, and the stirring is at 30-50rpm for 10-15 min.
8. The preparation method of the whitening mask liquid according to claim 4, characterized by comprising the following steps: in step S6, the homogenizing is carried out for 10-15 minutes, and the heat preservation is carried out for 5-10 minutes.
9. The preparation method of the whitening mask liquid according to claim 4, characterized by comprising the following steps: in step S6, the first cooling is to cool to 55-60 ℃, and the first stirring is to stir at 40-60rpm for 5-10 minutes.
10. The preparation method of the whitening mask liquid according to claim 4, characterized by comprising the following steps: in step S6, the temperature is reduced to 40-45 ℃ for the second time, and the second stirring is carried out for 5-10 minutes at the rotating speed of 40-60 rpm.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111370309.6A CN113908076A (en) | 2021-11-18 | 2021-11-18 | Whitening mask liquid and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111370309.6A CN113908076A (en) | 2021-11-18 | 2021-11-18 | Whitening mask liquid and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113908076A true CN113908076A (en) | 2022-01-11 |
Family
ID=79247583
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202111370309.6A Pending CN113908076A (en) | 2021-11-18 | 2021-11-18 | Whitening mask liquid and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113908076A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115670968A (en) * | 2022-10-31 | 2023-02-03 | 梅晔生物医药股份有限公司 | Composition and daily chemical product with anti-inflammatory and allergy-relieving effects |
| CN116747173A (en) * | 2023-07-19 | 2023-09-15 | 广州耀为生物科技有限公司 | Whitening and freckle-removing inclusion suitable for sensitive muscles and preparation method and application thereof |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107714539A (en) * | 2017-10-27 | 2018-02-23 | 广州君研生物科技有限公司 | Whitening and spot eliminating cream |
| CN108066218A (en) * | 2017-12-28 | 2018-05-25 | 广州蜜妆生物科技有限公司 | A kind of composition of whitening skin lightening |
| CN109010110A (en) * | 2018-08-28 | 2018-12-18 | 广州皓雨投资有限公司 | A kind of water-soluble composition with the anti-oxidant whitening function of moisturizing, facial mask and preparation method thereof |
| CN112618457A (en) * | 2020-12-31 | 2021-04-09 | 泉后(广州)生物科技研究院有限公司 | Chloasma-removing composition and preparation method and application thereof |
-
2021
- 2021-11-18 CN CN202111370309.6A patent/CN113908076A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107714539A (en) * | 2017-10-27 | 2018-02-23 | 广州君研生物科技有限公司 | Whitening and spot eliminating cream |
| CN108066218A (en) * | 2017-12-28 | 2018-05-25 | 广州蜜妆生物科技有限公司 | A kind of composition of whitening skin lightening |
| CN109010110A (en) * | 2018-08-28 | 2018-12-18 | 广州皓雨投资有限公司 | A kind of water-soluble composition with the anti-oxidant whitening function of moisturizing, facial mask and preparation method thereof |
| CN112618457A (en) * | 2020-12-31 | 2021-04-09 | 泉后(广州)生物科技研究院有限公司 | Chloasma-removing composition and preparation method and application thereof |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115670968A (en) * | 2022-10-31 | 2023-02-03 | 梅晔生物医药股份有限公司 | Composition and daily chemical product with anti-inflammatory and allergy-relieving effects |
| CN115670968B (en) * | 2022-10-31 | 2023-08-25 | 梅晔生物医药股份有限公司 | Composition with anti-inflammatory and allergy-relieving effects and daily chemical product |
| CN116747173A (en) * | 2023-07-19 | 2023-09-15 | 广州耀为生物科技有限公司 | Whitening and freckle-removing inclusion suitable for sensitive muscles and preparation method and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN113908076A (en) | Whitening mask liquid and preparation method thereof | |
| CN104146897B (en) | A kind of cosmetics with white-skinned face function | |
| CN110314130B (en) | Whitening and repairing stock solution and preparation method thereof | |
| CN108653014A (en) | A kind of whitening patch-lightening cosmetic and preparation method thereof | |
| CN112618457A (en) | Chloasma-removing composition and preparation method and application thereof | |
| CN108066209A (en) | A kind of whitening and spot eliminating cream and preparation method thereof | |
| CN105853297A (en) | Oil-control acne-prevention cosmetic containing cedrela sinensis extract and preparing method of oil-control acne-prevention cosmetic | |
| CN110279628A (en) | A kind of cosmetic composition and its preparation of moisturizing of releiving | |
| CN104000773A (en) | Natural antioxidant composite cosmetic and preparation method thereof | |
| CN110623888A (en) | Herbal soothing essence and preparation method thereof | |
| CN108785214A (en) | A kind of anti-blue light damage compound and its application in cosmetics | |
| CN104783237A (en) | Fresh dryness-moistening milk-flavored pecan kernels and preparation method thereof | |
| CN112137933A (en) | Composition with whitening, moisturizing and repairing effects | |
| CN111481482B (en) | Composition for repairing basal layer and preparation method and application thereof | |
| CN108703932A (en) | A kind of shampoo and preparation method thereof added with functional components | |
| CN113975215A (en) | Whitening cream and preparation method thereof | |
| CN108210415A (en) | The processing method that a kind of capsicum red pigment silk slides lipstick | |
| CN112641671A (en) | Moisturizing composition and preparation process thereof | |
| CN113749998A (en) | Composite acne-removing cream and preparation method thereof | |
| KR101458382B1 (en) | Speedy Hair Coloring Composition For Protecting Skin Coloration | |
| CN106265374A (en) | A kind of freckle-removing mask and preparation technology thereof | |
| CN110613654A (en) | Polypeptide compact mask liquid and preparation method thereof | |
| CN106309270B (en) | A kind of whitening cosmetic compound and preparation method | |
| CN110151569A (en) | A kind of moisturizing beauty essence and preparation method thereof | |
| CN110151605A (en) | A kind of natural tea olein China cream and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220111 |
|
| RJ01 | Rejection of invention patent application after publication |